Nurse Practitioner, Gerontology · Southfield, MI
NPI
1518336080
Since 2015
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
17515 W 9 Mile Rd, 375
Southfield, MI, 48075
Phone (248) 559-0950
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$861K
8,253 prescriptions
Company payments, 2025
$1,525
From 12 companies
Medicare prescription drug claims, 2024
In 2024, the drug Charlene Walton Windham prescribed most often to Medicare patients was Atorvastatin Calcium, with 571 prescriptions and refills. In total Charlene Walton Windham wrote 8,253 Medicare prescriptions that cost $861K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 571 | 572 | 92 | $30K |
| Levothyroxine Sodium Generic | 353 | 353 | 43 | $3,246 |
| Metoprolol Succinate Generic | 264 | 264 | 39 | $3,209 |
| Furosemide Generic | 231 | 231 | 38 | $1,263 |
| Amlodipine Besylate Generic | 230 | 230 | 37 | $5,275 |
| Gabapentin Generic | 226 | 226 | 31 | $6,762 |
| Losartan Potassium Generic | 207 | 207 | 33 | $4,735 |
| Omeprazole Generic | 185 | 185 | 26 | $12K |
| Lisinopril Generic | 179 | 179 | 31 | $2,519 |
| Duloxetine Hcl Generic | 179 | 179 | 19 | $16K |
| Pantoprazole Sodium Generic | 163 | 163 | 25 | $10K |
| Eliquis Apixaban | 153 | 153 | 26 | $86K |
| Metformin Hcl Generic | 147 | 147 | 19 | $2,393 |
| Rosuvastatin Calcium Generic | 143 | 143 | 18 | $13K |
| Tamsulosin Hcl Generic | 138 | 138 | 21 | $7,295 |
Brand drugs: 917 claims; generic drugs: 7,261 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charlene Walton Windham $1,525 ($1,525 in general payments such as food, travel and fees) from 12 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $239.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $239 |
| Medtronic, Inc. MDT | 1 | $132 |
| Genzyme Corporation SNY | 1 | $126 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $126 |
| Abbvie Inc. ABBV | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $125 |
| Novo Nordisk Inc NVO | 1 | $125 |
| GlaxoSmithKline, LLC. GSK | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $113 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.